Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Watson

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Nature|September 1, 2022
Comprehensive evidence implies a higher social cost of CO<sub>2</sub>Kevin Rennert, Frank Errickson, Brian C Prest, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2003
A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomesTimothy J Ley, Patrick J Minx, Matthew J Walter, et al.
Oncoimmunology|April 30, 2024
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytesJoel Kidman, Rachael M Zemek, John-William Sidhom, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Histology-Derived Signatures Predict Recurrence Risk and Chemotherapy Benefit in Randomized Trials of Early Breast CancerFrederick M Howard, Anran Li, Sara Kochanny, et al.
NPJ Breast Cancer|November 12, 2021
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightnessOtto Metzger-Filho, Katharine Collier, Sarah Asad, et al.
Breast Cancer Research and Treatment|December 18, 2012
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancerCynthia X Ma, Matthew J C Ellis, Gina R Petroni, et al.
Blood|February 14, 2008
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemiaMichael H Tomasson, Zhifu Xiang, Richard Walgren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2017
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.
Blood|May 15, 2007
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropeniaDaniel C Link, Ghada Kunter, Yumi Kasai, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2026
Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer RecurrenceNgoc-Kim Nguyen, Anran Li, Sara Kochanny, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Nature|September 1, 2022
Comprehensive evidence implies a higher social cost of CO<sub>2</sub>Kevin Rennert, Frank Errickson, Brian C Prest, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2003
A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomesTimothy J Ley, Patrick J Minx, Matthew J Walter, et al.
Oncoimmunology|April 30, 2024
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytesJoel Kidman, Rachael M Zemek, John-William Sidhom, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Histology-Derived Signatures Predict Recurrence Risk and Chemotherapy Benefit in Randomized Trials of Early Breast CancerFrederick M Howard, Anran Li, Sara Kochanny, et al.
NPJ Breast Cancer|November 12, 2021
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightnessOtto Metzger-Filho, Katharine Collier, Sarah Asad, et al.
Breast Cancer Research and Treatment|December 18, 2012
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancerCynthia X Ma, Matthew J C Ellis, Gina R Petroni, et al.
Blood|February 14, 2008
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemiaMichael H Tomasson, Zhifu Xiang, Richard Walgren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2017
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.
Blood|May 15, 2007
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropeniaDaniel C Link, Ghada Kunter, Yumi Kasai, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2026
Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer RecurrenceNgoc-Kim Nguyen, Anran Li, Sara Kochanny, et al.
Pageof 11